-
BioHarvest Sciences Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis
Analyze will assess the Capability of its Red Grape Cell (RGC) Botanical Composition to Advertise Eye Wellness Study is very first to display likely abilities of BioHarvest’s Botanical-Synthesis technology to offer reliable APIs, adjuvants and medicines for pharmaceutical field Vancouver, British Columbia, and Rehovot, Israel–(Newsfile Corp. – February 14, 2023) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (“BioHarvest” or the “Company”) has announced a collaboration with the International Neurorehabilitation Institute (INI) (https://inirehab.com/) in Lutherville, Maryland to execute a clinical trial to assess the ability of its RGC composition to endorse eye well being. The examine will be led by Dr. Daniel Becker, Director of the INI and Assistant Professor…
-
Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Introduction In 2020, at least 2·2 billion people were affected by blindness and vision impairment globally: 91·75{a5ceed037b574a4d8c6b44a0a7290437cee40655417128da3b56d864fe64414f} of these individuals had moderate or severe vision impairment, 87·68{a5ceed037b574a4d8c6b44a0a7290437cee40655417128da3b56d864fe64414f} of whom lived in low-income and middle-income countries (LMICs). 1 Burton MJ Ramke J Marques AP et al. The Lancet Global Health commission on global eye health: vision beyond 2020. As the LMIC with the largest population in the world, China has 8·69 million citizens with blindness. Population ageing and growth, as well as urbanisation, have shifted the spectrum of blindness-causing eye diseases to non-communicable conditions, and cataracts, glaucoma, age-related macular degeneration, diabetic retinopathy, and pathological myopia have become the leading blindness-causing eye…